348340 — Neuromeka Co Cashflow Statement

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for Neuromeka Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-8,271	-6,594	-8,201	-17,654	-16,755
Depreciation
Amortisation
Non-Cash Items	2,167	4,750	1,030	5,378	718
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	1,113	-101	-1,729	-1,165	-8,215
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-4,016	-1,056	-7,999	-12,434	-21,930
Capital Expenditures	-299	-293	-3,323	-30,601	-13,787
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	2,489	-4,335	-15,938	-15,798	30,355
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	2,190	-4,628	-19,261	-46,400	16,568
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	4,373	13,497	26,113	57,113	15,371
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	2,554	7,831	-1,149	-1,726	10,068